Cf. Close et al., Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study, DIABET MED, 16(11), 1999, pp. 918-925
Aims To determine risk factors for the development of persistent microalbum
inuria (albumin excretion rate (AER) greater than or equal to 30 mu g/min)
in Type 1 diabetes mellitus.
Methods One hundred and forty-eight initially normotensive Type 1 diabetic
patients with normal albumin excretion (<30 mu g/min) were followed prospec
tively in hospital diabetes outpatient clinics for a median of 7 years, Mai
n outcome measures were: progression to persistent microalbuminuria (albumi
n excretion rate greater than or equal to 30 mu g/min on at least two conse
cutive occasions); rate of change of albumin excretion rate; development of
arterial hypertension (systolic blood pressure >160 mmHg and/or diastolic
blood pressure > 95 mmHg or commencement of antihypertensive therapy).
Results In a median follw-up period of 7 years (range 6 months to 8 years),
14 patients progressed to persistent microalbuminuria, a cumulative incide
nce of 11% (95% confidence interval 6.36-16.94), AER remained persistently
< 30 mu g/min in 109 subjects and 25 developed intermittent microalbuminuri
a, In those who developed persistent microalbuminuria, baseline AER (16.2 (
13.9-19.1) vs, 5.2 (3,8-9,2) mu g/min, P<0.01), blood pressure (136 (123-14
8)/80 (74-85) vs, 121 (118-124)/72 (70-73) mmHg, P < 0.05), and HbA(1) (10.
2 (9.1-11.4) vs, 9.0 (8.7-9.4)%, P < 0.05) were higher than in those who co
ntinued to have persistent normoalbuminuria, retinopathy was more severe an
d height (1.64 (1.57-1.71) vs, 1.70 (1.69-1.72) m, P < 0.05) less. In multi
variate analysis, baseline AER was the strongest predictor of the developme
nt of persistent microalbuminuria (P < 0.0001), followed by mean arterial p
ressure (P = 0.02) and HbA(1) (P = 0.05).
Conclusions The level of AER, raised blood pressure and poor glycaemic cont
rol are the most important predictors of the development of microalbuminuri
a in Type 1 diabetes.